Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Queensland Health
Cantor Fitzgerald
Boehringer Ingelheim
Cerilliant
Federal Trade Commission
Mallinckrodt
Colorcon
Daiichi Sankyo

Generated: October 17, 2018

DrugPatentWatch Database Preview

Apothecon Company Profile

« Back to Dashboard

What is the competitive landscape for APOTHECON, and what generic and branded alternatives to APOTHECON drugs are available?

APOTHECON has one hundred and fourteen approved drugs.

There are three tentative approvals on APOTHECON drugs.

Summary for Apothecon
US Patents:0
Tradenames:77
Ingredients:47
NDAs:114

Drugs and US Patents for Apothecon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon VELOSEF cephradine INJECTABLE;INJECTION 061976-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Apothecon ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075583-004 Aug 22, 2000 DISCN No No ➤ Sign Up ➤ Sign Up
Apothecon AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062860-005 Feb 5, 1988 DISCN No No ➤ Sign Up ➤ Sign Up
Apothecon LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 075223-001 Nov 20, 1998 DISCN No No ➤ Sign Up ➤ Sign Up
Apothecon CEPHALEXIN cephalexin FOR SUSPENSION;ORAL 062987-001 Jul 25, 1989 DISCN No No ➤ Sign Up ➤ Sign Up
Apothecon OPHTHAINE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 008883-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Apothecon TRIMOX amoxicillin FOR SUSPENSION;ORAL 062154-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Apothecon

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apothecon CAPOZIDE 25/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-001 Oct 12, 1984 4,217,347 ➤ Sign Up
Apothecon STADOL PRESERVATIVE FREE butorphanol tartrate INJECTABLE;INJECTION 017857-001 Approved Prior to Jan 1, 1982 3,819,635 ➤ Sign Up
Apothecon CAPOZIDE 50/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-004 Oct 12, 1984 4,105,776 ➤ Sign Up
Apothecon CAPOZIDE 50/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-004 Oct 12, 1984 4,217,347 ➤ Sign Up
Apothecon KLOTRIX potassium chloride TABLET, EXTENDED RELEASE;ORAL 017850-001 Approved Prior to Jan 1, 1982 4,140,756 ➤ Sign Up
Apothecon CAPOZIDE 25/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-001 Oct 12, 1984 4,105,776 ➤ Sign Up
Apothecon CAPOZIDE 25/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-002 Oct 12, 1984 4,105,776 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
Cantor Fitzgerald
Citi
Teva
Daiichi Sankyo
Harvard Business School
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.